SCHEMBL6205007

SCHEMBL6205007

CC1C(=O)C=CC=C1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28515648 0.79 ALDH1A1 (0.33)
SCHEMBL9089960 0.76
SCHEMBL27434209 0.76
SCHEMBL27501079 0.75
SCHEMBL1081929 0.75 TSHR (0.33)
SCHEMBL4243463 0.75
SCHEMBL8890225 0.75
SCHEMBL9282299 0.75
SCHEMBL8890214 0.75
SCHEMBL29778183 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3438108-B1 PHENYL [A]INDOLE[2,3-G]QUINOLIZINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2022-08-10 EP claimed
EP-3438108-B1 PHENYL [A]INDOLE[2,3-G]QUINOLIZINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2022-08-10 EP disclosed
CN-108101870-B Preparation method of active ingredient for selectively treating glaucoma and related salt thereof 盐城师范学院 2020-03-06 CN disclosed
CN-108101870-B Preparation method of active ingredient for selectively treating glaucoma and related salt thereof 盐城师范学院 2020-03-06 CN disclosed
EP-1572660-A1 ISOQUINOLINONE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS X-Ceptor Therapeutics, Inc. (US) 2005-09-14 EP disclosed
WO-2004058717-A1 ISOQUINOLINONE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS X-CEPTOR THERAPEUTICS, INC. (US) 2004-07-15 WO disclosed
CN-1371425-A Plant gene expression controlled by constitutive plant V-ATPASE promoters BASF PLANT SCIENCE AG (DE) 2002-09-25 CN disclosed